Furthermore, microvessel density, defined with anti-CD31 Ab staining, was reduced in mice treated with anti-mouse CCL2 Ab, suggesting that CCL2 produced by stromal cells, but not cancer cells, plays a critical role in tumor growth and angiogenesis during disease progression in this BC model [34]. This evidence concerns the gene CCL2 and cancer.